Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease

Neuroscience Letters

Volumn 223, Issue 1, 1997, Pages 29-32

  Taddei, Kevin ^a   Clarnette, Roger ^b   Gandy, Samuel E ^c   Martins, Ralph N ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Osborne Park Hospital   (Australia)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Amyloid; Alzheimer's disease; Apolipoprotein E; Blood plasma; Chromosome 19; Down's syndrome; Genotypes

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 19; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DOWN SYNDROME; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 0031043673     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13394-8     Document Type: Article

References (23)

1. Baker, R.J., GLIM 3.77 reference guide. In Numerical Algorithms Group, GLIM 3.77 Reference Manual, The Royal Statistical Society, Oxford, 1985.
2. Corder, E.H., Saunders, A.M. and Strittmatter, W.J. et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
3. Diagnostic and Statistical Manual of Mental Disorders, (DMS-III-R), 3rd edn. revised, American Psychiatric Association Press, Washington, DC, 1987.
4. Goate, A., Chartier-Harlin, M.C. and Mullan, M. et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349 (1991) 704-706.
5. Jarvik, G.P., Wijsman, E.M., Kukull, W.A., Schellenberg, G.D., Yu, C. and Larson, E.B., Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study, Neurology, 45 (1995) 1092-1096.
6. LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S. and Frail, D.E., Isoform-specific binding of apolipoprotein E to beta-amyloid, J. Biol. Chem., 269 (1994) 23403-23406.
7. Lehtimäki, T., Pirttilä, T., Mehta, P.D., Wisniewski, H.M., Frey, H. and Nikkari, T., Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease, Hum. Genet., 95 (1995) 39-42.
8. Martins, R.N., Clarnette, R. and Fisher, C. et al., ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome, NeuroReport, 6 (1995) 1513-1516.
9. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K., Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. USA, 82 (1985) 4245-4249.
10. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34 (1984) 939-944.
11. Saunders, A.M., Schmader, K. and Breitner, J.C. et al., Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases, Lancet, 342 (1993) 710-711.
12. Saunders, A.M., Strittmatter, W.J. and Schmechel, D. et al., Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43 (1993) 1467-1472.
13. Schmechel, D.E., Saunders, A.M. and Strittmatter, W.J. et al., Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 9649-9653.
14. Sherrington, R., Rogaev, E.I. and Liang, Y. et al., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375 (1995) 754-760.
15. Strittmatter, W.J., Saunders, A.M. and Schmechel, D. et al., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 1977-1981.
16. Strittmatter, W.J., Weisgraber, K.H. and Huang, D.Y. et al., Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 8098-8102.
17. Tomlinson, B.E., Ageing and the dementias. In J.H. Adams and L.W. Duchen (Eds.), Greenfield's Neuropathology, Oxford University Press, New York, 1992, pp. 1284-1410.
18. Ueki, A., Kawano, M., Namba, Y., Kawakami, M. and Ikeda, K., A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease, Neurosci. Lett., 163 (1993) 166-168.
19. van Duijn, C.M., de Knijff, P. and Cruts, M. et al., Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease, Nature Genet., 7 (1994) 74-78.
20. Wisniewski, K.E., Wisniewski, H.M. and Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome, Ann. Neurol. (US), 17 (1985) 278-282.
21. Yamada, T., Kondo, A. and Takamatsu, J. et al., Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease, Neurol. Sci., 129 (1995) 56-61.
22. Yang, D.S., Smith, J.D., Zhou, Z., Gandy, S.E. and Martins. R.N., Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3 and E4 isoforms and to isoforms from human plasma, J. Neurochem., (1997) in press.
23. Zhou, Z., Smith, J.D. and Greengard, P. et al., Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ∈3 but not type ∈4 isoform of native apolipoprotein E, Mol. Med., 2 (1996) 175-180.